What is Triumeq?

Category: Prescription Drugs


See also: Dolutegravir Lamivudine

Triumeq is a medication consisting of dolutegravir, abacavir, and lamivudine. It is a single tablet regimen used for treatment of HIV.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 1
Mild 7
None 9

Commonly reported side effects and conditions associated with Triumeq

Side effect Patients
Decreased alcohol tolerance 1
Depressed mood 1
Difficulty staying asleep 1
Excessive thirst (polydipsia) 1
Nausea 1
Vomiting 1


Based on patients currently taking Triumeq

Dosage Patients
600-50-300 mg daily 3
1 tablet(s) daily 2


Currently taking Triumeq

Duration Patients
2 - 5 years 6
Adherence Evaluations
Always 17
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 3
Not at all hard to take 14
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 1
$25-49 0
< $25 5
Not specified 11

What people switch to and from

Patients started taking Triumeq after stopping:

Treatment Patients
Abacavir-lamivudine (Epzicom) 4
Dolutegravir (Tivicay) 4
Raltegravir (Isentress) 3
Abacavir-lamivudine-zidovudine (Trizivir) 2
Emtricitabine-Tenofovir (Truvada) 2

Show all 12 treatments patients report switching from

Last updated:
There are no evaluations for Triumeq.